title: [Streptococcus suis type 2: emerging pathogen producer of meningitis].
authors.forename: Irene Ma
authors.initials: IM
authors.lastname: Baena
authors.forename: Carmen
authors.initials: C
authors.lastname: Fernández
authors.forename: Julián
authors.initials: J
authors.lastname: Sánchez
authors.forename: Macarena
authors.initials: M
authors.lastname: Calvente
authors.forename: Vicente
authors.initials: V
authors.lastname: Aguadero
mesh_terms: D000437:Alcoholism / Q000150:complications; D002439:Cefotaxime / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging / Q000453:epidemiology / Q000382:microbiology*; D004198:Disease Susceptibility; D024901:Drug Resistance, Multiple, Bacterial; D004781:Environmental Exposure; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D016920:Meningitis, Bacterial / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D008875:Middle Aged; D012423:Rural Health; D013030:Spain; D013290:Streptococcal Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D017011:Streptococcus suis / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*
chemical_list: D002439:Cefotaxime